Product image of Meropenem Actavis (Meropenem) supplied by GNH India

Meropenem Actavis

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Actavis (Meropenem)

Meropenem, the active ingredient in Meropenem Actavis, is a carbapenem presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, urinary tract infections, bacterial meningitis, severe sepsis, hospital‑acquired pneumonia, and complicated skin and soft tissue infections in hospitalized patients.

GNH India supplies Meropenem Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

  • Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens.
  • Complicated urinary tract infections: eradicates resistant Gram‑negative organisms causing severe UTIs.
  • Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitis caused by susceptible bacteria.
  • Severe sepsis and septic shock: rapidly reduces bacterial load in systemic infections.
  • Hospital‑acquired pneumonia: covers typical and atypical pathogens in ventilated patients.
  • Complicated skin and soft tissue infections: treats resistant Staphylococcus and Gram‑negative infections.

How It Works

  • Meropenem binds to penicillin‑binding proteins on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bactericidal death. The molecule is stable against most β‑lactamases, giving it activity against a wide range of Gram‑positive, Gram‑negative and anaerobic organisms.

Side Effects

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools.
  • Headache: transient cranial discomfort.
  • Injection site pain: discomfort during infusion.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction.
  • Seizures: risk in patients with renal impairment or CNS disorders.
  • Clostridioides difficile colitis: severe intestinal infection.
  • Stevens‑Johnson syndrome: rare mucocutaneous reaction.

Precautions & Warnings

When using Meropenem, consider the following precautions.

  • Renal function: adjust dose in patients with impaired renal clearance.
  • Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy.
  • CNS disorders: monitor for seizures, especially in patients with pre‑existing neurological disease.
  • Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited.
  • Concomitant nephrotoxic drugs: monitor renal parameters when combined with aminoglycosides or vancomycin.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem may interact with other medicines; awareness of major and moderate interactions is important.

Major Interactions (Avoid)

  • Valproic acid: may reduce serum valproate levels, risking seizure breakthrough.
  • High‑dose aminoglycosides: increased risk of nephrotoxicity.
  • Loop diuretics: may exacerbate electrolyte disturbances.
  • Probenecid: can increase meropenem plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect; monitor INR.
  • Rifampin: may lower meropenem levels; consider dose adjustment.
  • Oral contraceptives: potential reduction in efficacy; advise alternative contraception.

Frequently Asked Questions

Meropenem Actavis is an intravenous carbapenem antibiotic indicated for the treatment of serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, bacterial meningitis, severe sepsis, hospital‑acquired pneumonia, and complicated skin and soft tissue infections.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the final step of peptidoglycan cross‑linking. This leads to cell‑wall weakening, osmotic lysis and rapid bactericidal activity against a broad spectrum of Gram‑positive, Gram‑negative and anaerobic organisms.

The dose of Meropenem Actavis is individualized by the prescribing clinician based on the type and severity of infection, patient weight, renal function and other clinical factors. No fixed regimen is provided here.

Safety data for Meropenem in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order, submit an enquiry on the Meropenem Actavis product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Meropenem offers a broad spectrum of activity and stability against many β‑lactamases, similar to other carbapenems like imipenem or ertapenem. Compared with non‑carbapenem agents, it often provides superior coverage of resistant Gram‑negative and anaerobic pathogens, making it a preferred option for severe, hospital‑acquired infections.

Meropenem Actavis should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect from light, and do not freeze or shake the solution before use.

The product is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically via a controlled IV infusion over a prescribed period, following aseptic technique and appropriate dilution guidelines.

Serious adverse events include anaphylaxis, seizures (especially in patients with renal impairment or CNS disorders), Clostridioides difficile‑associated colitis, and rare severe skin reactions such as Stevens‑Johnson syndrome. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics should avoid this medication. Caution is also advised for individuals with severe renal impairment, uncontrolled epilepsy, or a history of severe allergic reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT